Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102


No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.

Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Phipps AI, David SP, Hsu L, Harrison TA, Hutter CM, Duggan DJ, White E, Chan AT, Peters U.

Menopause. 2014 Apr;21(4):415-20. doi: 10.1097/GME.0b013e31829e498d.


Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.

Passarelli MN, Phipps AI, Potter JD, Makar KW, Coghill AE, Wernli KJ, White E, Chan AT, Hutter CM, Peters U, Newcomb PA.

Cancer Res. 2013 Jan 15;73(2):767-75. doi: 10.1158/0008-5472.CAN-12-2484.


Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease.

Hall KT, Nelson CP, Davis RB, Buring JE, Kirsch I, Mittleman MA, Loscalzo J, Samani NJ, Ridker PM, Kaptchuk TJ, Chasman DI.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2160-7. doi: 10.1161/ATVBAHA.114.303845.


Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women.

Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA.

Genes Chromosomes Cancer. 2011 Nov;50(11):875-86. doi: 10.1002/gcc.20913.


Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.

Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schönfels W, Hampe J, Schafmayer C, Völzke H, Frank B, Brenner H, Försti A, Hemminki K, Chang-Claude J.

Endocr Relat Cancer. 2011 Mar 9;18(2):265-76. doi: 10.1530/ERC-10-0264.


The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I.

Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.


Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.

Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE.

Hum Genet. 2007 Aug;122(1):41-9.


Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.

Udler MS, Azzato EM, Healey CS, Ahmed S, Pooley KA, Greenberg D, Shah M, Teschendorff AE, Caldas C, Dunning AM, Ostrander EA, Caporaso NE, Easton D, Pharoah PD.

Int J Cancer. 2009 Dec 1;125(11):2687-96. doi: 10.1002/ijc.24678.


Distribution of the Val108/158Met polymorphism of the COMT gene in healthy Mexican population.

González-Castro TB, Tovilla-Zárate C, Juárez-Rojop I, Pool García S, Genis A, Nicolini H, López Narváez L.

Gene. 2013 Sep 10;526(2):454-8. doi: 10.1016/j.gene.2013.05.068.


Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk.

Wedrén S, Rudqvist TR, Granath F, Weiderpass E, Ingelman-Sundberg M, Persson I, Magnusson C.

Carcinogenesis. 2003 Apr;24(4):681-7.


Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.

Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):838-47.


Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfoundland.

Campbell PT, Edwards L, McLaughlin JR, Green J, Younghusband HB, Woods MO.

Clin Cancer Res. 2007 Jul 1;13(13):3783-8.


Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study.

Tofteng CL, Abrahamsen B, Jensen JE, Petersen S, Teilmann J, Kindmark A, Vestergaard P, Gram J, Langdahl BL, Mosekilde L.

Calcif Tissue Int. 2004 Aug;75(2):123-32.


Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.

Lin G, Zhao J, Wu J, Andreevich O R, Zhang WH, Zhang Y, Yu L.

Genet Mol Res. 2013 Dec 10;12(4):6442-53. doi: 10.4238/2013.December.10.5.


Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.

Sazci A, Ergul E, Kucukali I, Kilic G, Kaya G, Kara I.

Brain Res Mol Brain Res. 2004 Dec 6;132(1):51-6.


Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival.

Garcia-Albeniz X, Nan H, Valeri L, Morikawa T, Kuchiba A, Phipps AI, Hutter CM, Peters U, Newcomb PA, Fuchs CS, Giovannucci EL, Ogino S, Chan AT.

Carcinogenesis. 2013 Feb;34(2):292-8. doi: 10.1093/carcin/bgs335.


Diabetes, metformin use, and colorectal cancer survival in postmenopausal women.

Cossor FI, Adams-Campbell LL, Chlebowski RT, Gunter MJ, Johnson K, Martell RE, McTiernan A, Simon MS, Rohan T, Wallace RB, Paulus JK.

Cancer Epidemiol. 2013 Oct;37(5):742-9. doi: 10.1016/j.canep.2013.04.015.


Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.

Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB.

Cancer Res. 1998 May 15;58(10):2107-10.


Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia.

Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aki H, Sumitani S, Itakura M, Ohmori T.

J Neural Transm (Vienna). 2007 Feb;114(2):255-9.

Items per page

Supplemental Content

Support Center